SCHEMBL13021070

SCHEMBL13021070

CC(=O)C(CCCCNC(=O)CN1C(=O)C=CC1=O)NC(=O)CN1C(=O)C=CC1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RRM1 P23921 1/20 0.39
▸ ALB P02768 3/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ PABPC1 P11940 1/20 0.38
▸ SIRT5 Q9NXA8 2/20 0.36
▸ POLB P06746 2/20 0.35
▸ HDAC3 O15379 1/20 0.34
▸ HDAC4 P56524 1/20 0.34
▸ HDAC1 Q13547 1/20 0.34
▸ HDAC7 Q8WUI4 1/20 0.34
▸ HDAC2 Q92769 1/20 0.34
▸ HDAC10 Q969S8 1/20 0.34
▸ HDAC11 Q96DB2 1/20 0.34
▸ HDAC8 Q9BY41 1/20 0.34
▸ HDAC6 Q9UBN7 1/20 0.34
▸ HDAC9 Q9UKV0 1/20 0.34
▸ HDAC5 Q9UQL6 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22109548 0.83 C3AR1 (0.39) RRM1ALBMEN1KMT2AKDM4E
SCHEMBL13783660 0.79 MEN1 (0.34) RRM1ALBMEN1KMT2AKDM4E
SCHEMBL13021071 0.78 HDAC3 (0.47) RRM1ALBSIRT5POLBHDAC3
SCHEMBL13137486 0.78 AKT1 (0.47) RRM1ALBMEN1KMT2ASIRT5
SCHEMBL18165064 0.77 HDAC1 (0.41) MEN1KMT2AKDM4EMAPTPABPC1
SCHEMBL17722911 0.77 FURIN (0.35) ALBMEN1KMT2ASIRT5POLB
SCHEMBL16507725 0.77 ALB (0.39) ALBMEN1KMT2APOLBFOLH1
SCHEMBL12056281 0.77 ALB (0.39) ALBMEN1KMT2APOLBFOLH1
SCHEMBL22688009 0.76 GLP1R (0.44) RRM1ALBFOLH1
SCHEMBL28710245 0.76 GLP1R (0.44) RRM1ALBFOLH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7858648-B2 Nanotube complexes are water soluble, nontoxic; use in delivering biologicals such as DNA for gene therapy, DNA vaccines; amine salts derived from diethylenetriaminepentaacetic acid-modified nanotubes with anion such as DNA CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) 2010-12-28 — — US disclosed
US-20080076816-A1 Nanotube complexes are water soluble, nontoxic; use in delivering biologicals such as DNA for gene therapy, DNA vaccines; amine salts derived from diethylenetriaminepentaacetic acid-modified nanotubes with anion such as DNA THE UNIVERSITY OF MANCHESTER (GB) 2008-03-27 — — US disclosed
US-20080008760-A1 Functionalized carbon nanotubes, a process for preparing the same and their use in medicinal chemistry CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2008-01-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080008760-A1 Functionalized carbon nanotubes, a process for preparing the same and their use in medicinal chemistry CD47, CCR7, CCR6 RRM1 3566/4885ALB 556/4885MEN1 1372/4885
US-20080076816-A1 Nanotube complexes are water soluble, nontoxic; use in delivering biologicals such as DNA for gene therapy, DNA vaccines; amine salts derived from diethylenetriaminepentaacetic acid-modified nanotubes with anion such as DNA DNTT, EEA1, DCTN1 RRM1 3945/4885ALB 1726/4885MEN1 2790/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback